Use of interferon beta-1a

MSMED_INTERFERONBETA1A

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L03AB07

586

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

546

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

546

diagram downward connector

Include endpoints None

546

diagram downward connector
MSMED_INTERFERONBETA1A

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 521 427 94
Unadjusted prevalence (%) 0.17 0.25 0.07
Mean age at first event (years) 37.42 37.24 38.20

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: MSMED_INTERFERONBETA1A – Use of interferon beta-1a
GWS hits:

Survival analyses between endpoints

Plot

before Use of interferon beta-1a
after Use of interferon beta-1a

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of interferon beta-1a